Delivering on the promise of Gene Writing™
We deliver our RNA Gene Writers as all RNA products using proprietary lipid nanoparticles or LNPs.
LNPs can safely and effectively deliver nucleic acids to cells without eliciting a robust immune response as is common with viral delivery vectors.
Manufacture Gene Writer mRNA and template RNA
mRNA-encoded Gene Writer and template RNA are packaged into a lipid nanoparticle
RNA-LNP composition of matter is administered to the patient, and enters the cell type of interest
After entering the target cell, the Gene Writer mRNA is translated into protein and binds the template RNA
The Gene Writer-template complex is shuttled to the nucleus and effects the desired alteration into the genome
LNPs are the optimal delivery vehicle for Gene Writers
LNPs constitute an advantaged delivery vehicle over viral methods to dispatch targeted genetic instructions.
Established safety track record
The widespread use of mRNA vaccines has demonstrated the broad safety profile of LNP delivery of RNA therapeutics.
Scalable and cost-effective to manufacture
Viral vector manufacturing is often costly and a bottleneck for therapeutic delivery.
Re-dosable, if needed
Unlike viral vectors, LNPs are not recognized as foreign by the human immune system.
Transient expression of engineering machinery
Gene Writing machinery will be short-lived inside the cell, reducing the risk of genotoxicity.
Solving delivery with our proprietary LNP technology
Existing therapeutic solutions to many genetic diseases involve the liver, where conventional LNPs naturally accumulate. We are advancing our proprietary technology to direct LNPs to go not only to the liver but beyond. Targeted delivery of our Gene Writers to tissues beyond the liver is essential to writing in the code of life precisely where a therapeutic change is needed.